SCHEMBL7652744

SCHEMBL7652744

O=C(Cc1ccc(Cl)cc1)NCC1CCc2[nH]c(C(c3ccccc3)(c3ccccc3)c3ccccc3)nc2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM7 Q14831 1/20 0.38
ROCK2 O75116 1/20 0.38
ROCK1 Q13464 1/20 0.38
CCR2 P41597 3/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
POLB P06746 2/20 0.37
SIGMAR1 Q99720 1/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6849610 0.76 LMNA (0.43) GRM7ROCK2ROCK1POLBLMNA
SCHEMBL6846987 0.74 CCR2 (0.41) GRM7CCR2CNR1CNR2SIGMAR1
SCHEMBL6851333 0.73 CCR2 (0.41) GRM7CCR2CNR1CNR2POLB
SCHEMBL6851432 0.66 P2RX7 (0.38) CCR2KDM4EALDH1A1KMT2AMEN1
SCHEMBL6849558 0.66 CCR2 (0.41) CCR2POLBKDM4EALDH1A1MAPT
SCHEMBL25894418 0.66 NPC1 (0.74) CNR1CNR2POLBLMNAALDH1A1
SCHEMBL6849769 0.65 CCR2 (0.43) CCR2LMNAKMT2AMEN1RAB9A
SCHEMBL6846803 0.65 CCR2 (0.41) CCR2POLBLMNAALDH1A1MAPT
SCHEMBL6849628 0.64 CCR2 (0.41) CCR2POLBKDM4EALDH1A1MAPT
SCHEMBL2409477 0.64 NPC1 (0.60) ROCK2ROCK1CNR1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020058659-A1 Imidazole compounds HIGH POINT PHARMACEUTICALS, LLC 2002-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058659-A1 Imidazole compounds HRH3, HRH4, HRH2 GRM7 654/4885ROCK2 3680/4885ROCK1 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.